World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
103
Citations
64959
World Ranking
7172
National Ranking
271

Pieter Wesseling publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Pieter Wesseling sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 476 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Pieter Wesseling D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Pieter Wesseling sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 103 D-Index — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Pieter Wesseling is affiliated with the University of Amsterdam in the Netherlands. Their research primarily spans the field of medicine, with significant contributions in biochemistry, genetics, and molecular biology. Their work has addressed various subfields including genetics, molecular biology, neurology, pulmonary and respiratory medicine, and radiology, nuclear medicine, and imaging.

The research topics that they have focused on include glioma diagnosis and treatment, radiomics and machine learning applications in medical imaging, neuroblastoma research and treatments, management of meningioma and schwannoma, cancer genomics and diagnostics, brain metastases and treatment, and chromatin remodeling in cancer.

Pieter Wesseling has been a frequent contributor to several publication venues with notable numbers of publications in the following:

  • Neuro-Oncology
  • Acta Neuropathologica
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuro-Oncology Advances
  • Cancer Research

They have collaborated extensively with various coauthors throughout their career. Frequent coauthors include:

  • Pim J. French
  • Martin J. van den Bent
  • Mariëtte E.G. Kranendonk
  • Stefan M. Pfister
  • Andreas von Deimling

Some of Pieter Wesseling's recent papers are:

  • "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary," 2021, Neuro-Oncology
  • "EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours," 2021, Annals of Oncology
  • "cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading," 2020, Brain Pathology
  • "Sarcoma classification by DNA methylation profiling," 2021, Nature Communications
  • "Glioma progression is shaped by genetic evolution and microenvironment interactions," 2022, Cell

Best Publications

  • Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

    Roger Stupp;Monika E. Hegi;Warren P. Mason;Martin J. van den Bent

  • The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

    David N Louis;Arie Perry;Pieter Wesseling;Daniel J Brat

  • DNA methylation-based classification of central nervous system tumours

    David Capper;David Capper;David Capper;David T. W. Jones;Martin Sill;Volker Hovestadt

  • Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

    Genevieve Schindler;David Capper;David Capper;Jochen Meyer;Wibke Janzarik

  • Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

    Christian Hartmann;Christian Hartmann;Jochen Meyer;Jörg Balss;David Capper

  • The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells

    Dennis S. U. Lindau;Paul R. Gielen;Michiel Kroesen;Pieter Wesseling;Pieter Wesseling

  • New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

    Dominik Sturm;Dominik Sturm;Brent A. Orr;Umut H. Toprak;Volker Hovestadt

  • Overcoming the blood-brain tumor barrier for effective glioblastoma treatment

    O. van Tellingen;B. Yetkin-Arik;M.C. de Gooijer;P. Wesseling;P. Wesseling

  • RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

    Myron G. Best;Nik Sol;Irsan Kooi;Jihane Tannous

  • Diffuse glioma growth: a guerilla war

    An Claes;Albert J. Idema;Pieter Wesseling

  • WHO 2016 Classification of gliomas

    Pieter Wesseling;Pieter Wesseling;David Capper;David Capper;David Capper

  • International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

    David N. Louis;Arie Perry;Peter Burger;David W. Ellison

  • EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.

    E. Le Rhun;M. Weller;D. Brandsma;M. Van den Bent

  • Germline mutation of INI1/SMARCB1 in familial schwannomatosis.

    Theo J.M. Hulsebos;Astrid S. Plomp;Ruud A. Wolterman;Els C. Robanus-Maandag

  • DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly

    Ilari Scheinin;Daoud Sie;Henrik Bengtsson;Mark A. van de Wiel

  • cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.

    David N. Louis;Pieter Wesseling;Kenneth Aldape;Daniel J. Brat

  • Longitudinal molecular trajectories of diffuse glioma in adults

    Floris P. Barthel;Kevin C. Johnson;Frederick S. Varn;Anzhela D. Moskalik

  • Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study

    Martin J van den Bent;Brigitta Baumert;Sara C Erridge;Michael A Vogelbaum;Michael A Vogelbaum

  • cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant

    David N. Louis;Caterina Giannini;David Capper;Werner Paulus

  • IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

    Martin J. van den Bent;Hendrikus J. Dubbink;Yannick Marie;Alba A. Brandes

Frequent Co-Authors

Andreas von Deimling
Andreas von Deimling Heidelberg University
Wolfgang Wick
Wolfgang Wick German Cancer Research Center
Stefan M. Pfister
Stefan M. Pfister German Cancer Research Center
Andrey Korshunov
Andrey Korshunov German Cancer Research Center
Martin J. van den Bent
Martin J. van den Bent Erasmus University Rotterdam
Felix Sahm
Felix Sahm University Hospital Heidelberg
Johan M. Kros
Johan M. Kros Erasmus University Rotterdam
Michael Weller
Michael Weller University of Zurich
David Capper
David Capper Charité - University Medicine Berlin
Arend Heerschap
Arend Heerschap Radboud University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in alternative routes or career pathways related to medicine, pursuing nursing or healthcare degrees online can offer flexibility and a quicker path to advancement. Many students now look for rn to bsn online programs without clinicals, which allow working registered nurses to upgrade their qualifications without the need for traditional on-site clinical experiences. This option is ideal for those balancing professional and personal commitments.

For those aiming for leadership roles or advanced practice, considering a fastest dnp program could help fast-track your doctorate and get you into high-level positions sooner. Alternatively, some individuals seek the easiest dnp programs to simplify their academic journey, focusing on programs with more accessible prerequisites and flexible coursework.

If you are looking to enter the healthcare field quickly, a 6 month lpn program online might be the right fit. These accelerated options prepare you for entry-level nursing roles in less than a year. Ultimately, online pathways can provide multiple entry and advancement opportunities in the healthcare sector, fitting diverse needs and timelines.

Best Scientists Citing Pieter Wesseling

Trending Scientists

Recently Published Articles